Reuters Examines Chronic Disease In Developing Countries, Future Of Drug Prices

Main Category: Pharma Industry / Biotech Industry
Also Included In: Public Health
Article Date: 22 Jan 2010 - 5:00 PDT

Current ratings for:
'Reuters Examines Chronic Disease In Developing Countries, Future Of Drug Prices'

Patient / Public:not yet rated

Healthcare Prof:not yet rated

"Global health projections leave little doubt that chronic diseases are rapidly overtaking infectious diseases, such as malaria, AIDS and tuberculosis (TB), as the world's biggest killers - a shift emphasized by a recent World Health Organization (WHO) report on global health risks," Reuters writes in a story analyzing the future of drug pricing in the developing world. Longer life-spans in developing countries "and changing patterns of food, alcohol and tobacco consumption are creating a 'double burden' for poor nations, piling chronic diseases on top of infectious diseases," the news service writes.

As the demand for chronic disease treatment spreads to the developing world, "the price of many of these medicines and their unsuitability for emerging markets are high barriers to access," Reuters writes, adding that "pharmaceutical bosses will also be under pressure to join patent pools to promote downward price pressure on drugs for major chronic diseases by increasing the number of producers, and may face legal challenges to force them to allow in more generic competition."

The article details current efforts by pharmaceutical companies, lays out other ways to increase chronic disease treatment access and includes recent statistics that show increasing chronic disease in developing countries. The article also includes comments by Tido von Schoen-Angerer, of Medecins Sans Frontieres (MSF), on his support for drug patent pools to help drive down the costs of therapies used to treat chronic disease.

"Until now companies had been able to separate out drugs that are needed in developing countries from drugs that primarily make up their market in rich countries," von Schoen-Angerer said. "But the divide which saw infectious diseases as primarily affecting the poor and chronic diseases affecting the rich is now changing, and that will demand a change of strategy" (Kelland, 1/20).

This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org.

© Henry J. Kaiser Family Foundation. All rights reserved.



Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Reuters Examines Chronic Disease In Developing Countries, Future Of Drug Prices." Medical News Today. MediLexicon, Intl., 22 Jan. 2010. Web.
25 May. 2012. <http://www.medicalnewstoday.com/releases/176816.php>
APA
Kaiser. (2010, January 22). "Reuters Examines Chronic Disease In Developing Countries, Future Of Drug Prices." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/176816.php.

Please note: If no author information is provided, the source is cited instead.


Add Your Opinion On This Article

'Reuters Examines Chronic Disease In Developing Countries, Future Of Drug Prices'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »